Regulatory News In Brief
This article was originally published in The Tan Sheet
Executive Summary
FDA warns about supplement GMP violations; ERSP asks Lunada to pull Amberen claims; supplement disease claims axed in U.K.; Herbalife recalls mislabeled mixes; authentic and counterfeit Maxiloss Weight Advanced on recall; MHRA warns of poison Chinese medicines.